Treatment of rheumatoid arthritis by antibodies directed against class II MHC antigens.
Sany
J
J
Department of Immuno-Rheumatology, Hôpital Gui-de-Chauliac, Montpellier, France.
D000818:Animals; D000906:Antibodies / Q000276:immunology*; D000911:Antibodies, Monoclonal / Q000276:immunology / Q000627:therapeutic use; D001172:Arthritis, Rheumatoid / Q000628:therapy*; D001696:Biomechanical Phenomena; D000949:Histocompatibility Antigens Class II / Q000276:immunology*; D006801:Humans; D007167:Immunotherapy; D007518:Isoantibodies / Q000276:immunology / Q000502:physiology
D000906:Antibodies; D000911:Antibodies, Monoclonal; D000949:Histocompatibility Antigens Class II; D007518:Isoantibodies